Barclays
LUNG icon

Barclays’s Pulmonx LUNG Stock Holding History

Barclays’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$44.4K Sell
34,138
-649,297
-95% -$894K ﹤0.01% 4356
2026
Q1 		$882K Buy
683,435
+211,184
+45% +$349K ﹤0.01% 2827
2025
Q4 		$1.04M Buy
472,251
+132,569
+39% +$249K ﹤0.01% 3401
2025
Q3 		$550K Buy
339,682
+67,036
+25% +$140K ﹤0.01% 3749
2025
Q2 		$706K Buy
272,646
+168,441
+162% +$664K ﹤0.01% 3557
2025
Q1 		$701K Buy
104,205
+37,694
+57% +$267K ﹤0.01% 3312
2024
Q4 		$452K Sell
66,511
-27,598
-29% -$182K ﹤0.01% 3885
2024
Q3 		$780K Buy
94,109
+1,679
+2% +$12.1K ﹤0.01% 3515
2024
Q2 		$586K Sell
92,430
-20,378
-18% -$157K ﹤0.01% 2949
2024
Q1 		$1.05M Sell
112,808
-24,515
-18% -$287K ﹤0.01% 3087
2023
Q4 		$1.75M Buy
137,323
+44,385
+48% +$462K ﹤0.01% 3024
2023
Q3 		$960K Buy
92,938
+53,001
+133% +$614K ﹤0.01% 2364
2023
Q2 		$524K Buy
39,937
+22,539
+130% +$276K ﹤0.01% 2726
2023
Q1 		$195K Buy
17,398
+8,114
+87% +$80.1K ﹤0.01% 3804
2022
Q4 		$78.3K Buy
9,284
+7,734
+499% +$73.6K ﹤0.01% 4369
2022
Q3 		$26K Sell
1,550
-1,011
-39% -$18.6K ﹤0.01% 3978
2022
Q2 		$37K Sell
2,561
-3,768
-60% -$77.6K ﹤0.01% 4158
2022
Q1 		$157K Buy
+6,329
New +$163K ﹤0.01% 3564

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ECM
ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Barclays's LUNG Position: Q2 2026 in Review

Barclays reduced its Pulmonx (LUNG) stake by 95% in Q2 2026, selling an estimated $894K and leaving 34,138 shares worth $44.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4356.

Barclays first reported a position in LUNG in Q1 2022 and has held it in 18 quarters since. The position peaked at $1.75M in Q4 2023. 108 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.

  • Barclays held 34,138 shares of Pulmonx worth $44.4K as of Q2 2026.
  • Barclays sold 649,297 Pulmonx shares in Q2 2026, an estimated $894K.
  • Pulmonx made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #4356 holding.
  • Barclays first reported a position in Pulmonx in Q1 2022 and has held it in 18 quarters since.
  • Barclays's Pulmonx position peaked at $1.75M in Q4 2023.
  • 108 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.